MEDAPP S.A. ZY -10
MedApp S.A. develops solutions to support diagnostic imaging and digital medicine in Poland, rest of the European Union, and internationally. The company offers CarnaLife System, an analytical telemedicine system that enables physician to assess and monitor the health of patients and conduct consultations, as well as enable remote measurement, such as pulse oximeter, electrocardiograph, blood pre… Read more
MEDAPP S.A. ZY -10 (WQ1) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, MEDAPP S.A. ZY -10 (WQ1) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
MEDAPP S.A. ZY -10 - Net Assets Trend (None–None)
This chart illustrates how MEDAPP S.A. ZY -10's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for MEDAPP S.A. ZY -10 (None–None)
The table below shows the annual net assets of MEDAPP S.A. ZY -10 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to MEDAPP S.A. ZY -10's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
MEDAPP S.A. ZY -10 Competitors by Market Cap
The table below lists competitors of MEDAPP S.A. ZY -10 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Cosmos Technology International Berhad
KLSE:0261
|
$3.34 Million |
|
RFG Holdings Ltd
JSE:RFG
|
$3.34 Million |
|
HB Global Ltd
KLSE:5187
|
$3.34 Million |
|
Hour Loop Inc
NASDAQ:HOUR
|
$3.34 Million |
|
Noble Financials SA
WAR:IBS
|
$3.34 Million |
|
Solteq PLC
HE:SOLTEQ
|
$3.34 Million |
|
Universal Ibogaine Inc
PINK:IBOGF
|
$3.34 Million |
|
Jasnita Telekomindo Tbk PT
JK:JAST
|
$3.34 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MEDAPP S.A. ZY -10's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares MEDAPP S.A. ZY -10's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently MEDAPP S.A. ZY -10 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares MEDAPP S.A. ZY -10's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $1,807,324,866
- Average return on equity (ROE) among peers: -12.22%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| MEDAPP S.A. ZY -10 (WQ1) | €- | N/A | N/A | $3.34 Million |
| Schrödinger, Inc. (43Z) | $557.09 Million | -18.02% | 0.36x | $619.47 Million |
| DACHA STRATEGIC (7DC) | $40.24 Million | 0.65% | 0.08x | $81.97 Million |
| ABL Diagnostics Société anonyme (9BK0) | $6.77 Million | 0.80% | 1.20x | $379.13K |
| Zhejiang Taimei Medical Technology Co., Ltd. (A2V) | $1.04 Billion | -33.28% | 0.39x | $47.24 Million |
| ASCOM HLDG NA SF 0,50 (AH2N) | $80.00 Million | 16.88% | 1.43x | $190.62 Million |
| DocCheck AG (AJ91) | $18.14 Million | 3.32% | 0.15x | $18.00 Million |
| EM Systems Co. Ltd (EMO) | $17.69 Billion | 7.87% | 0.33x | $74.55 Million |
| Tempus AI (F3M) | $-1.38 Billion | 0.00% | 0.00x | $4.69 Billion |
| Pangenomic Health Inc. (LL3) | $2.24 Million | -118.14% | 0.15x | $4.82 Million |
| MeVis Medical Solutions AG (M3V) | $17.83 Million | 17.76% | 0.45x | $12.50 Million |